Atlanta Lung Cancer Symposium Agenda

Those with approved access to view the 2023 downloadable content, please enter the access code below. Please be advised that only paid registrants of the 2023 symposium will be provided access to this 2023 content.

The 2024 agenda is provided below.

Access Downloadable Content

Times provided are in ET
Agenda and faculty subject to change

October 26, 2024

7:55 AM

Welcome and Introductions

Suresh Ramalingam, MD, FACP, FASCO
Ticiana A. Leal, MD

Plenary 1: Locally Advanced/Advanced NSCLC/SCLC

Co-Chair: Ioana Bonta, MD

8:00 AM

Small Cell Lung Cancer: New Therapeutic Advances in 2024

Taofeek K. Owonikoko, MD, PhD

8:15 AM

First Line Therapy for Advanced NSCLC Without Driver Mutations

Julie Brahmer, MD

8:30 AM

Salvage Therapy for Advanced NSCLC: Reasons for Hope?

Karen L. Reckamp, MD

8:45 AM

Locally Advanced NSCLC: Radiotherapy Considerations

Sibo Tian, MD

9:00 AM

Locally Advanced NSCLC: Role of IO and Emerging Advances

Ticiana A. Leal, MD

9:15 AM

Panel Discussion

9:30 AM

Morning Symposium and Exhibits

Plenary 2: Early-Stage NSCLC

Co-Chairs: Mohan Krishnamachary, MD, and Ticiana Leal, MD

10:15 AM

Neoadjuvant Therapy for Resectable NSCLC

Paul Bunn, MD

10:30 AM

Early-Stage NSCLC: When is Sub-Lobar Resection Appropriate?

Onkar Khullar, MD, MSc

10:45 AM

Adjuvant Therapy for Oncogene-Addicted NSCLC

Jamie E. Chaft, MD

11:00 AM

DEBATE: Should Adjuvant IO be Given After Surgery Following Chemo-IO

Yes: John V. Heymach, MD, PhD
No: Ryan Gentzler, MD

11:40 AM

Panel Discussion

11:55 AM

Lunch Symposium and Exhibits

Plenary 3: Targeted Therapy in Advanced NSCLC

Co-Chairs: William S. Jonas, MD, and Jennifer W. Carlisle, MD

12:40 PM

EGFR Inhibition in Locally Advanced and Stage IV NSCLC

Suresh Ramalingam, MD, FACP, FASCO

12:55 PM

Treatment of ALK-Positive Advanced NSCLC

Shirish M. Gadgeel, MD

1:10 PM

KRAS Inhibition in Advanced NSCLC

John V. Heymach, MD, PhD

1:25 PM

Panel Discussion

1:40 PM

Afternoon Break and Exhibits

Plenary 4: Targeted Therapy in Advanced NSCLC II and Rare Thoracic Malignancies

Co-Chairs: Paul Gill, MD, and Steven McCune, MD, PhD

2:00 PM

Liquid Biopsy: Current and Future Applications

Valsamo Anagnostou, MD

2:15 PM

EGFR Exon 20 Insertion and Uncommon EGFR Mutations

Jennifer W. Carlisle, MD

2:30 PM

RET, MET and ROS1: Optimal Therapy and Emerging Agents

Conor E. Steuer, MD

2:45 PM

Systemic Therapy for HER-2, BRAF and NTRK

Gregory J. Riely, MD, PhD

3:00 PM

Rare Thoracic Malignancies: Mesothelioma and Thymic Malignancies

Fatemeh Ardeshir, MD, MSc

3:15 PM

Panel Discussion

3:30 PM

Closing Remarks and Adjourn